As a result, ductal (CA2, CK19, and SOX9)/pancreatic cancer (EpCAM and CD44) markers decreased and acinar markers (SYP and PTF1A) increased by inhibitor treatment in KiPCs (Figure 5B,D). The gene discussed is CD44; the disease is pancreatic neoplasm.